Notice of Budget Change in RFA-AI-24-006 Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed)
Notice Number:
NOT-AI-24-046

Key Dates

Release Date:

April 25, 2024

Related Announcements

  • March 27, 2024 - Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed).  See NOFO RFA-AI-24-006.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

This Notice is to inform potential applicants that the National Institute of Allergy and Infectious Diseases (NIAID) is revising the award budget language in the notice of funding opportunity, RFA-AI-24-006, Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed).

Currently reads:

Part 2. Full Text of Announcement

Section II. Award Information

Award Budget

Application budgets are not expected to exceed $850,000 in direct costs per year and need to reflect the actual needs of the proposed project.

Revised to read (in bold italics):

Part 2. Full Text of Announcement

Section II. Award Information

Award Budget

Application budgets are not expected to exceed $1,200,000 in direct costs per year and need to reflect the actual needs of the proposed project.

All other aspects of the NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Sara E. Woodson, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-761-6478
Email: woodsonse@niaid.nih.gov